Those already taking tirzepatide, or any other GLP-1 drug, are also excluded, according to protocols posted on clinicaltrials.gov, as are those with certain medical conditions or medical histories that researchers have determined could confound results
Most studies focus on oral supplements, though, not injections, and results are usually seen alongside diet and exercise changes
The result is a look commonly referred to as Ozempic Face, marked by facial hollowing, sagging skin, and visible signs of aging
Opdivo (nivolumab) injection, for intravenous use
A report from Impact Analytics estimates that these changing size curves could cost retailers up to $20 million annually due to misaligned inventory and excess production of larger sizes
Insurance coverage expansion through commercial plans and Medicare Advantage products improves treatment accessibility across demographic segments